HIV viral load
Feb 1, 2021
Article and Study Summary Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study Published in: Lancet. 2020;396 (10267):1994-2005...
Jul 6, 2020
Article and Study Summary: Outcomes of Three- Versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe Published in: J Acquir Immune Defic Syndr. 2020;84(2):162-172....
May 8, 2020
Article and Study Summary: Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): Findings from an open-label, non-inferiority, randomised controlled trial Published in: Lancet HIV. 2020;7 (4):e229-e237....
Jan 28, 2020
Rabkin M, Achwoka D, Akoth S, Boccanera R, Kimani M, Leting I, Madevu-Matson C, Mutei R, Nyaga L, Onyango C, Ouma C, Rondinelli I, Rumunyu P, Tsiouris F, Wakoli A, Walker L, Dougherty G J Assoc Nurses AIDS Care. 2020 Jan 24:1-8. doi: 10.1097/JNC.0000000000000158....
Nov 25, 2019
Phillips T, Mooba P, Brittain K, Gomba Y, Zerbe A, Myer L, Abrams E. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2019 November. doi: 10.1097/QAI.0000000000002236 Background: Integrated maternal and child health (MCH) services improve women’s...
